Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS Medisurgi's revenue per share for the
six
months ended in Mar. 2026 was ₹15.98.
KMS Medisurgi's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹35.99.
Warning Sign:
KMS Medisurgi Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of KMS Medisurgi was -12.70% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 3.30% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 10.60% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 1.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for KMS Medisurgi's Revenue per Share or its related term are showing as below:
BOM:540468'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -24.8 Med: 2.75 Max: 55.5
Current: 3.3
During the past 13 years, KMS Medisurgi's highest 3-Year average Revenue Per Share Growth Rate was 55.50% per year. The lowest was -24.80% per year. And the median was 2.75% per year.
BOM:540468's 3-Year Revenue Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 3.7
vs BOM:540468: 3.30
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
KMS Medisurgi Revenue per Share Related Terms
KMS Medisurgi Revenue per Share Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540468 vs ISRG, BDX, MDLN: Revenue per Share Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's PS Ratio distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
KMS Medisurgi's Revenue Per Share for the fiscal year that ended in Mar. 2026 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹35.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMS Medisurgi (BOM:540468) has a Revenue per Share of ₹35.99 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on KMS Medisurgi and its competitors.
Is KMS Medisurgi's Revenue per Share too high?
KMS Medisurgi's current Revenue per Share is ₹35.99. Overall, KMS Medisurgi has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's Revenue per Share compare to ISRG and BDX?
KMS Medisurgi's Revenue per Share of ₹35.99 can be compared against companies in the Medical Devices & Instruments industry. The industry median Revenue per Share is 3.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Devices & Instruments company?
The median Revenue per Share among Medical Devices & Instruments companies is 3.70, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median Revenue per Share is 3.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current Revenue per Share is ₹35.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
KMS Medisurgi (BOM:540468) has a current Revenue per Share of ₹35.99. The stock's GF Value™ is ₹111.52, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current Revenue per Share is ₹35.99. KMS Medisurgi's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current Revenue per Share is ₹35.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.52.
Key valuation signals for BOM:540468:
Revenue per Share: ₹35.99
GF Value™: ₹111.52 vs. price of ₹132.80 (19.1% above fair value)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
